Immunovant Inc (IMVT)

Nov 04, 2024

Emerald Mutual Fund Advisers Trust Has $5.24 Million Holdings in Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

Nov 04, 2024

Nov 02, 2024

Where are the Opportunities in (IMVT) - Stock Traders Daily

Nov 02, 2024

Nov 02, 2024

Analysts Set Immunovant, Inc. (NASDAQ:IMVT) Price Target at $48.10 - Defense World

Nov 02, 2024

Nov 02, 2024

Immunovant, Inc. (NASDAQ:IMVT) Position Boosted by abrdn plc - MarketBeat

Nov 02, 2024

Oct 30, 2024

Brokerages Set Immunovant, Inc. (NASDAQ:IMVT) Price Target at $48.10 - MarketBeat

Oct 30, 2024

Oct 29, 2024

Immunovant Announces Oral Presentation of Late Breaking Abstract for Phase 2 Graves' Disease Clinical Data at the 2024 American Thyroid Association (ATA) Annual Meeting - The Manila Times

Oct 29, 2024

Oct 29, 2024

Immunovant Announces Oral Presentation of Late Breaking Abstract for Phase 2 Graves’ Disease Clinical Data at the 2024 American Thyroid Association (ATA) Annual Meeting - ForexTV.com

Oct 29, 2024

Oct 26, 2024

Immunovant's chief medical officer sells $94,171 in stock By Investing.com - Investing.com Canada

Oct 26, 2024

Oct 25, 2024

Immunovant CTO Jay Stout sells $80,912 in stock By Investing.com - Investing.com Canada

Oct 25, 2024

Oct 25, 2024

Immunovant, Inc. (NASDAQ:IMVT) CTO Sells $80,912.20 in Stock - MarketBeat

Oct 25, 2024

Oct 25, 2024

Immunovant CTO Jay Stout sells $80,912 in stock - Investing.com India

Oct 25, 2024

Oct 25, 2024

Immunovant's chief medical officer sells $94,171 in stock - Investing.com India

Oct 25, 2024

Oct 25, 2024

Immunovant's chief legal officer Mark Levine sells shares worth $128,780 By Investing.com - Investing.com Australia

Oct 25, 2024

Oct 25, 2024

Immunovant's chief legal officer Mark Levine sells shares worth $128,780 - Investing.com

Oct 25, 2024

Oct 19, 2024

Immunovant CFO Eva Renee Barnett sells $94,172 in stock By Investing.com - Investing.com Australia

Oct 19, 2024

Oct 19, 2024

Immunovant's chief medical officer William Macias sells $91,782 in stock - Investing.com India

Oct 19, 2024

Oct 19, 2024

Immunovant's chief legal officer sells $82,339 in stock By Investing.com - Investing.com Australia

Oct 19, 2024

Oct 19, 2024

Immunovant's chief legal officer sells $82,339 in stock - Investing.com India

Oct 19, 2024

Oct 19, 2024

Exchange Traded Concepts LLC Buys 9,438 Shares of Immunovant, Inc. (NASDAQ:IMVT) - Defense World

Oct 19, 2024

Oct 19, 2024

Immunovant CFO Eva Renee Barnett sells $94,172 in stock - Investing.com

Oct 19, 2024

Oct 19, 2024

Immunovant CEO Peter Salzmann sells $261,845 in shares By Investing.com - Investing.com Australia

Oct 19, 2024

Oct 18, 2024

Immunovant CEO Peter Salzmann sells $261,845 in shares - Investing.com

Oct 18, 2024

Oct 18, 2024

Immunovant, Inc. (NASDAQ:IMVT) Insider Sells $91,782.52 in Stock - MarketBeat

Oct 18, 2024

Oct 16, 2024

Immunovant (NASDAQ:IMVT) Is In A Good Position To Deliver On Growth Plans - Simply Wall St

Oct 16, 2024

Oct 16, 2024

IMVT (Immunovant Inc) has impressive results - US Post News

Oct 16, 2024

Oct 15, 2024

Raymond James gives an Outperform recommendation for Immunovant Inc (IMVT) - Knox Daily

Oct 15, 2024

Oct 15, 2024

Analyzing Ratios: Immunovant Inc (IMVT)’s Financial Story Unveiled - The Dwinnex

Oct 15, 2024

Oct 14, 2024

Immunovant: Switching Lead Candidates Increases Risk (NASDAQ:IMVT) - Seeking Alpha

Oct 14, 2024

Oct 14, 2024

The Manufacturers Life Insurance Company Decreases Stake in Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

Oct 14, 2024

Oct 12, 2024

Immunovant CEO sells over $131k in company stock By Investing.com - Investing.com Australia

Oct 12, 2024

Oct 12, 2024

Immunovant CFO sells over $150k in company stock By Investing.com - Investing.com Australia

Oct 12, 2024

Oct 11, 2024

Immunovant Inc [IMVT] stock for 104,976 USD was sold by Levine Mark S. - Knox Daily

Oct 11, 2024

Oct 11, 2024

Trend Tracker for (IMVT) - Stock Traders Daily

Oct 11, 2024

Oct 11, 2024

Immunovant, Inc. (NASDAQ:IMVT) CEO Sells $131,837.60 in Stock - MarketBeat

Oct 11, 2024

Oct 11, 2024

Immunovant CEO sells over $131k in company stock - Investing.com India

Oct 11, 2024

Oct 11, 2024

Immunovant CFO sells over $150k in company stock - Investing.com

Oct 11, 2024

Oct 11, 2024

Noteworthy Friday Option Activity: IMVT, ALB, GCT - Nasdaq

Oct 11, 2024

Oct 10, 2024

Immunovant stock could attract strategic interest, says Raymond James By Investing.com - Investing.com UK

Oct 10, 2024

Oct 10, 2024

It would be worthwhile to take a closer look at Immunovant Inc (IMVT) - US Post News

Oct 10, 2024

Oct 10, 2024

Raymond James Reiterates "Outperform" Rating for Immunovant (NASDAQ:IMVT) - MarketBeat

Oct 10, 2024

Oct 10, 2024

Millennium Management LLC Sells 277,575 Shares of Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

Oct 10, 2024

Oct 09, 2024

Immunovant shares price target raised by Oppenheimer on positive trial data - Investing.com Canada

Oct 09, 2024

Oct 09, 2024

Oppenheimer Raises Immunovant (NASDAQ:IMVT) Price Target to $53.00 - MarketBeat

Oct 09, 2024

Oct 08, 2024

Analyzing Immunovant Inc (IMVT) After Recent Trading Activity - Knox Daily

Oct 08, 2024

Oct 08, 2024

Taking the lead: Immunovant Inc (IMVT) - SETE News

Oct 08, 2024

Oct 06, 2024

Dimensional Fund Advisors LP Reduces Stake in Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

Oct 06, 2024

Oct 05, 2024

Financial Analysis: SpringWorks Therapeutics (NASDAQ:SWTX) vs. Immunovant (NASDAQ:IMVT) - Defense World

Oct 05, 2024